Journals / Uzmanlık Sonrası Eğitim ve Güncel Gelişmeler Dergisi / 2007 / Cilt: 4 - Sayı: 1

Lipid profile changes among two groups of surgically menopausal women, using daily 0.625 mg oral CEE and weekly 3.9 mg TTS estrogen patch

Cerrahi menapozlu olgularda 0,625 mg. oral östrojen ile haftalık 3,9 mg. transdermal östrojenin lipid profili üzerine olan etkileri

Pages
47–50
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Hence individualization of hormone therapy is essential in monitoring those women with surgical menopause.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This prospective cohort study was an attempt to evaluate the lipid profile changes among two groups of surgically menopausal women, using daily 0.625 mg oral CEE and weekly 3.9 mg TTS estrogen patch.
📊
Key Findings & Data:Materials and Methods: Of 127 women associated with surgical menopause, 83 (63.5%) cases recieved CEE (group I) and 44 (34.7%) women administrated weekly 3.9 mg.
💡
Conclusion & Impact:Hence individualization of hormone therapy is essential in monitoring those women with surgical menopause.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Lipidler · Menopoz · Kolesterol

Abstract

This prospective cohort study was an attempt to evaluate the lipid profile changes among two groups of surgically menopausal women, using daily 0.625 mg oral CEE and weekly 3.9 mg TTS estrogen patch. Materials and Methods: Of 127 women associated with surgical menopause, 83 (63.5%) cases recieved CEE (group I) and 44 (34.7%) women administrated weekly 3.9 mg. TTS estrogen patch (group II). Age, body mass index (BMI), baseline systolic and diastolic blood pressures of all cases were recorded. Total cholesterol (TC), LDL, HDL and triglycerides (TG) levels were determined before and 6 months after treatment. Results: Man age, BMI, initial systolic and diastolic blood pressures were similar among both groups. TC (227±5.9 mg/dl) and TG levels (119±11.9 mg/dl) were higher in group II, prior to hormone therapy. When lipid levels were compared before and 6- months after treatment in each group, HDL levels was significantly increased in group I (p=0.01), whilst among group II, plasma HDL (p=0.08) level was increased and TG (p=0.002) level was decreased. Based on delta (_) values of each lipid parameter changes, only TG level decrease remained statistically significant in group II (p=0.03). Conclusion: Transdermal hormone therapy seems to be superior to the oral forms in improving the lipid profiles. Hence individualization of hormone therapy is essential in monitoring those women with surgical menopause.

Özet

Bu prospektif kohort çalışma, cerrahi menopozlu kadınlarda oral 0,625 mg. CEE ile haftalık 3,9 mg. TTS'nin lipit profili üzerine olan etkilerini araştırmak üzere planlanmıştır. Gereç ve Yöntemler: Yüzyirmiyedi cerrahi menopozlu hastadan 83 (%63,5) olgu 0,625 mg. CEE (grup I), 44 (%34.7) olgu ise 3,9 mg. transdermal TTS kullandı. Olguların yaş, vücut kitle indeksi (BMI), sistolik ve diyastolik tansiyonları kaydedildi. Total kolesterol, LDL, HDL ve trigiserit (TG) düzeyleri çalışmadan önce ve 6 ay sonra değerlendirildi. Bulgular: Ortalama yaş, BMI, sistolik ve diyastolik kan basınçları her iki grupta da benzerdi. Tedavi öncesi total kolesterol (227±5.9 mgdl) ve TG düzeyleri (119±11.9mg/dl) grup II'de daha yüksek düzeyde saptandı. Tedavi öncesi ve 6 ay sonrası lipit düzeyleri karşılaştırıldığında grup I'de HDL düzeyleri istatistiksel anlamlı (p=0,01) olarak artarken, grup II'de HDL artışı (p=0,08) ve TG azalışı (p=0,002) izlenmiştir. İki grup arasında lipit profili değişikliğinin yüzdesi karşılaştırıldığında sadece trigliserid değişiklikleri yüzdesi istatistiksel olarak farklıydı (p=0,03). Sonuç: Lipit profili olan etkisi değerlendirildiğinde transdermal hormon tedavisi oral tedaviye göre daha üstün tespit edilmiştir. Bu yüzden cerrahi menopozlu olguların takibinde hormon tedavisinin bireyselleştirilmesi önem taşımaktadır.

🔖

Cite This Article

HASSA, H., TANIR, H. M., TEKİN, B., ÖĞE, T., KAHRAMAN, S. (2007). Lipid profile changes among two groups of surgically menopausal women, using daily 0.625 mg oral CEE and weekly 3.9 mg TTS estrogen patch. Uzmanlık Sonrası Eğitim ve Güncel Gelişmeler Dergisi, Cilt: 4 - Sayı: 1, 47–50. https://ajindex.com/articles/320557

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Kessler C.M, Szymanski L.M, Shamsipour Z, Muesing R.A, Miller V.T. and Larosa J.C. Estrogen replacement therapy and coagulation: Relationship to lipit and lipoprotein changes Obstet Gynecol 1997; 89:326-331 2. Wild RA. Estrogens: effects on the cardiovascular tree. Obstet Gynecol 1996; 87: 27-35 3. Bass KM, Newschaffer CJ, Bush TL. Plasma lipoprotein levels as a predictor of cardiovascular death in women. Arch Intern Med 1993;153: 2209-2216 4. P.S. Roheim and B.F. Asztalos, Clinical significans of lipoprotein size and risk for coronary atherosclerosis, Clin Chem 1995;41:147-152 5. I.F. Godsland, Effects of postmenopausal hormone replacement therapy on lipit, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. Fertil Steril 2001; 75: 898-915 6. Notelovitz M, Gudat JC, Ware MD, Dougherty MC. Lipits and lipoproteins in women after oophorectomy and the response to oestrogen therapy. Br J Obstet Gynaecol 1983;90:171-177 7. Lobo RA, Speroff L. İnternational consensus conference on postmenopausal hormone therapy and the cardiovascular system. Fertil Steril 1994; 62:176-179 8. D.L. Sprecher. Triglycerides as a risk factor for coronary artery disease. Am J Cardiol 1998;82:49-56 9. Mattsson LA, Samsioe G, von Schoultz B, Uvebrant M, Wiklund I. Transdermally administered oestradiol combined with oral medroxyprogesterone acetate: The effects on lipoprotein metabolism in postmenopausal women. Br J Obstet Gynaecol 1993;100:450-453.